KB195 / Kaleido Biosci - LARVOL DELTA

A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects (clinicaltrials.gov) - P=N/A; N=47; Completed; Sponsor: Kaleido Biosciences

Clinical • New trial

UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder (clinicaltrials.gov) - P2; N=24; Recruiting; Sponsor: Kaleido Biosciences; Trial completion date: Nov 2020 ➔ Nov 2021; Trial primary completion date: Oct 2020 ➔ Oct 2021

Clinical • Trial completion date • Trial primary completion date

UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder (clinicaltrials.gov) - P2; N=24; Recruiting; Sponsor: Kaleido Biosciences; Trial completion date: Jul 2020 ➔ Nov 2020; Trial primary completion date: Apr 2020 ➔ Oct 2020

Clinical • Trial completion date • Trial primary completion date